Search results
Results from the WOW.Com Content Network
The drug or other substance has a potential for abuse less than the drugs or other substances in schedules I and II. The drug or other substance has a currently [1] accepted medical use in treatment in the United States. Abuse of the drug or other substance may lead to moderate or low physical dependence or high psychological dependence.
(A) 100 grams (3.5 oz) or more of a mixture or substance containing a detectable amount of a narcotic drug in schedule I or II other than a narcotic drug consisting of (i) coca leaves (ii) a compound, manufacture, salt, derivative, or preparation of coca leaves (iii) a substance chemically identical thereto
Except when dispensed directly to an ultimate user by a practitioner other than a pharmacist, no controlled substance in Schedule II, which is a prescription drug as determined under the Federal Food, Drug, and Cosmetic Act (21 USC 301 et seq.), may be dispensed without the written or electronically transmitted (21 CFR 1306.08) prescription of ...
Find out what the a Schedule 3 drug is, and what it means for marijuana users. Skip to main content. Sign in. Mail. 24/7 Help. For premium support please call: 800-290-4726 more ways ...
The House passed legislation Thursday to permanently classify fentanyl as a Schedule 1 drug, which lawmakers say will allow law enforcement to be better equipped to prosecute drug traffickers and ...
This measure asks voters to change parts of Proposition 47, a controversial ballot initiative passed in 2014 that turned some nonviolent felonies into misdemeanors.
The Drug Enforcement Administration was created in 1973. The "Just Say No" campaign was started by first lady, Nancy Reagan in 1984. The campaign intended to educate the general population on the risks associated with drug use. [3] The Anti-Drug Abuse Acts of 1986 and 1988 increased penalties and established mandatory sentencing for
The Comprehensive Drug Abuse Prevention and Control Act of 1970, Pub. L. 91–513, 84 Stat. 1236, enacted October 27, 1970, is a United States federal law that, with subsequent modifications, requires the pharmaceutical industry to maintain physical security and strict record keeping for certain types of drugs. [1]